ISO 18562 Testing

Biocompatibility Evaluation of Breathing Gas Pathways in Healthcare Applications 

What is it and Why is it Important?

ISO 18562 is the standard for toxicity studies in respiratory devices and components required by the regulatory bodies of the United States and European Union. The testing searches for three sources of potentially hazardous materials that are being emitted by the device and/or its components. The emission of these hazardous particles could enter the respiratory system, causing dangerous conditions for the patient.

Scroll down for more infomation

The three areas of this standard are as follows and are all conducted at PSN:

ISO Certified Labs

Our state-of-the-art Testing Laboratory is ISO/IEC 17025:2017 accredited and fully equipped to support all your material and product testing needs.


Our lab operates as a stand-alone service, as well as being integrated into our full spectrum of engineering services.


PSN’s experience and expertise crosses over a wide range of industries, products, and manufacturing processes, allowing our team to be a best-in-class choice to help determine and correct the risks associated with device manufacturing.

ISO 18562

In 2017, ISO 18562 was released and added to ISO 10993-1 as the standard for toxicity studies in respiratory devices and components, required by United States and European Union regulatory bodies. The standard analyzes three areas of potentially hazardous materials:


ISO 18562-2: Particles

ISO 18562-3: VOCs

ISO 18562-4: Leachables


The PSN Test Lab is equipped with industry leading equipment for qualification of devices and the generation of data for FDA submissions. At PSN, we are so much more than just a test lab. Our team of scientists and engineers are trained to isolate confounding variables and provide clear analysis to guide the commercialization of new medical devices.

Plastics Services Network (PSN)


5368 Kuhl Road
Erie, PA 16510
Email: info@PSNLabs.com
Phone: 814.464.0790
Fax: 814.464.0794

Go to article: Home | Is medical AI racist?Go to article: In This IssueGo to article: NSFGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: NewsGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: Coronavirus Executive BriefingGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: uvexGo to article: Covid-19 pandemic has prompted rural hospitals to adopt EHR platformsGo to article: Mi3 Medical IntelligenceGo to article: Swisstec 3DGo to article: The Covid-19 treatment landscape is growingGo to article: Mecmesin Company InsightGo to article: MecmesinGo to article: Industrial Engineering Group Go to article: Multi-pronged approach needed to restore consumer confidence in safety of elective proceduresGo to article: Asahi InteccGo to article: KSP Go to article: Wearable technology market to reach $64bn by 2024 in spite of turbulence caused by Covid-19Go to article: SemecsGo to article: Covid-19 testing still mattersGo to article: PSN LabsGo to article: ProByLas Company Insight Go to article: The medical industry briefingGo to article: ESMAGo to article: Chromatic 3D MaterialsGo to article: Does the vaginal speculum need a redesign?Go to article: AerotechGo to article: REL8Go to article: A race to the bottom: how AI encodes racial discrimination within medicineGo to article: Watlow Company Insight Go to article: WatlowGo to article: PPE shortage? Mini factories could be the answerGo to article: CoherentGo to article: INDO-MIMGo to article: Building blocks: 3D-printed ‘bone bricks’ could help save limbsGo to article: Industrial Indexing Systems Company Insight Go to article: Industrial Indexing SystemsGo to article: iFixit: how uncaging equipment repair could transform med techGo to article: How do you build a secure contact tracing app?Go to article: ElectroCraftGo to article: TiodizeGo to article: SIM AutomationGo to article: Power up: self-charging medical devices could be on the wayGo to article: Helbling Go to article: Bioinicia Go to article: CureApp: could digital therapeutics be a lifeline for NASH patients?Go to article: ICF MercantileGo to article: The key list powered by GlobalDataGo to article: STSGo to article: Deals in brief powered by GlobalDataGo to article: AccumoldGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2 ) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: mdi ConsultantsGo to article: EventsGo to article: Electronic Sensor TechnologyGo to article: Next Issue